20-02-03 Personalized Cervical Cancer Prevention: The Next Generation of Abnormal Result Management via the ASCCP Consensus Guidelines

23rd Annual Premier Women's Healthcare Virtual Conference

0.8 CE (NCC 3)

Individuals who did not register for the Conference can now purchase individual session recordings. Anyone who was registered for the Main Conference (October 16-17, 2020) will have access to all recordings, free of any additional charge, through November 15, 2021.


Kim Choma DNP, WHNP-BC

Women’s Health Nurse Practitioner

Ob/Gyn Associates of North Jersey

Teaneck, New Jersey  

Aimee Chism Holland DNP, WHNP-BC, FNP-BC, FAANP

Associate Professor 

University of Alabama at Birmingham 

Birmingham, Alabama  

Intended Audience:

Women’s Health Nurse Practitioners (WHNPs), WHNP students, Certified Nurse Midwives (CNMs) and other nurse practitioners and advanced practice clinicians who care for women. 

Activity Number:  20-02-03  

CE Approval Period:  Now through November 15, 2021

Approved CE Credit Hours:  0.8 CE contact hour credit 

Accreditation Statement:

This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for 0.8 CE contact hours, zero hours of pharmacology content.  

Program Description

A review of the 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests.  

Educational Objectives:

At the conclusion of this activity, the learner will be able to:

  • Understand new evidence underlying a risk-based paradigm for managing abnormal cervical cancer screening test results.
  • Recognize the process through which risk-thresholds were chosen to guide the clinical actions of immediate treatment, colposcopy, and short-interval follow up.
  • Gain insight with the new technology (app). 

Faculty Disclosures: 

Kim Choma has no disclosures to report. 

Aimee Chism Holland is on the Bayer speakers' bureau and is the PI for an AANP research study.

Successful Completion: 

Successful completion of this activity requires the participant to: 

  1. Read the educational objectives, disclosures and disclaimers.
  2. Watch the session recording
  3. Complete the session evaluation
  4. Print your CE certificate (the certificate will be stored on the NPWH E-Learning site under My Transcripts).
  5. These steps must be completed prior to the course expiration date
  6. Some courses required a post-test.  If a post test is required participants must earn a score of 70%.   

Therapeutic Disclosures: 

Faculty members determine the content of the CE activity.  The content does not necessarily represent the views of NPWH.  Clinicians are responsible for evaluating information presented in relation to generally accepted standards of care and individual patient characteristics.  

Commercial Support:  

This activity has no commercial support 

You must be signed in to access this course.  You can sign in at the top right-hand corner of the page.  

**If you are an NPWH member, were once a member, or have completed CE activities with NPWH in the past, you have a username and password in the system.  Please DO NOT create a new account.  If you do not remember your username or password, please either click on the “forgot username” or “forgot password” link at the bottom of the sign on screen or call the NPWH office at (202) 543-9693 ext. 81


Non-Member/Inactive Member Student Member
$30.00 $15.00 $15.00
20-02-03  Personalized Cervical Cancer Prevention: The Next Generation of Abnormal Result Management via the ASCCP Consensus Guidelines